心臟去颤器市场规模、份额、成长分析，按类型、按患者类型、按最终用户、按地区 - 行业预测，2025 年至 2032 年

预计心臟去颤器市场规模将在 2023 年达到 151 亿美元，并从 2024 年的 163.2 亿美元增长到 2032 年的 304.4 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.1%。

心臟设备市场的成长得益于技术进步、心臟麻痹发生率的增加、公众意识的增强以及政府和医疗保健组织的倡议。值得注意的是，快速反应復兴研究有限公司 (Rapid Response Revival Research Ltd.) 的首款个人家用自动体外心臟心臟去颤器(AED) CellAED 已获得 CE 认证，符合公司的扩大策略。儘管治疗方法不断进步，心臟麻痹仍然是心血管死亡的主要原因，推动了植入式心臟整流去颤器(ICD) 和外部 AED 的创新和需求。 Ami Italia 等公司提供各种多功能心臟去颤器，而微创医疗已成为中国心律管理领域的领导者，报告指出 2022 年上半年收益成长了 95%。在迪拜 AED 分销和培训计划等倡议的推动下，新兴市场的认知度不断提高，预计将推动市场持续成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 技术分析
• 案例研究
• 专利分析

心臟去颤器市场规模（按类型）

• 市场概况
• 植入式心臟整流去颤器
  • 经静脉植入式心臟整流去颤器
  • 皮下植入式心臟整流去颤器
• 体外心臟去颤器
  • 手动和半自动体外电击器
  • 全自动体外电击器
  • 心臟去颤器

心臟去颤器市场规模（依患者类型）

• 市场概况
• 成人
• 孩子们

心臟去颤器市场规模（按最终用户划分）

• 市场概况
• 医院、诊所和心臟中心
• 院前护理
• 公共接取市场
• 居家照护
• 替代护理设施
• 其他最终用户

心臟去颤器市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Medtronic（Ireland）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Koninklijke Philips NV（Netherlands）
• ZOLL Medical Corporation（Asahi Kasei）（USA/Japan）
• Nihon Kohden Corporation（Japan）
• Stryker（USA）
• BIOTRONIK SE & Co. KG（Germany）
• MicroPort Scientific Corporation（China）
• Schiller AG（Switzerland）
• Mindray Medical International Ltd.（China）
• Defibtech LLC（USA）
• LivaNova PLC（UK）
• Cardiac Science Corporation（USA）
• Bexen Cardio（Spain）
• Physio-Control Inc.（USA）
• CU Medical Systems Co., Ltd.（South Korea）
• Metrax GmbH（Germany）
• BPL Medical Technologies（India）
• Avive Solutions Inc.（USA）

结论和建议

Defibrillator Market size was valued at USD 15.1 billion in 2023 and is poised to grow from USD 16.32 billion in 2024 to USD 30.44 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The growth of the cardiac device market is fueled by advancements in technology, rising incidences of sudden cardiac arrest, heightened public awareness, and initiatives from government and healthcare organizations. Notably, Rapid Response Revival Research Ltd. received CE certification for CellAED, the first home-use personal AED, aligning with their expansion strategy. Despite treatment advancements, sudden cardiac arrest remains a leading cause of cardiovascular mortality, driving innovation and demand for implantable cardioverter-defibrillators (ICDs) and external AEDs. Companies like Ami Italia offer a range of versatile defibrillators, while Microport has emerged as a leader in China's cardiac rhythm management sector, reporting a 95% revenue increase in H1 2022. Growing awareness in developing markets, bolstered by initiatives such as Dubai's AED distribution and training programs, promises continued market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Defibrillator market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Defibrillator Market Segments Analysis

Global Defibrillator Market is segmented by Type, Patients type, End Users and region. Based on Type, the market is segmented into Implantable cardioverter defibrillators and External defibrillators. Based on Patients type, the market is segmented into Adult and Pediatrics. Based on End Users, the market is segmented into Hospitals, Clinics and Cardiac centres, Pre-hospital care settings, Public access markets, Home care settings, Alternate care facilities and Other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Defibrillator Market

The defibrillator market is significantly driven by the rising prevalence of cardiovascular diseases, including coronary artery disease and cardiac arrest, which pose a major health risk to populations globally. In the United States alone, the CDC reported around 695,000 deaths from cardiovascular diseases in 2021, with coronary artery disease notably increasing the likelihood of sudden cardiac deaths due to arrhythmias. Furthermore, the Coronary Artery Disease Foundation highlighted that approximately 356,000 out-of-hospital cardiac arrests occur annually in the country. Contributing factors such as obesity, hypertension, dyslipidemia, diabetes, and an aging population exacerbate this issue, as older individuals face higher risks of developing serious heart-related conditions and arrhythmias, fueling the demand for defibrillators in healthcare settings.

Restraints in the Defibrillator Market

The defibrillator market faces certain restraints primarily due to the high costs associated with advanced models such as implantable cardioverter defibrillators (ICDs) and other sophisticated devices. These financial constraints can hinder their widespread adoption, especially in areas where healthcare budgets are constrained or insurance coverage is insufficient. As a result, the elevated price of these critical medical devices poses a significant challenge, restraining overall market growth and limiting access for healthcare providers and patients in need of these life-saving technologies. Addressing this cost barrier is essential for fostering greater adoption and improving patient outcomes in various regions.

Market Trends of the Defibrillator Market

The defibrillator market is experiencing a significant surge driven by rapid technological advancements focused on improving device performance and patient outcomes. Innovations such as AI algorithms enhance precision in detecting cardiac rhythms, thereby increasing the likelihood of successful resuscitation. Additionally, the integration of wireless connectivity facilitates remote monitoring and data transmission, allowing healthcare providers to make informed decisions in real-time. User interface enhancements are also making defibrillators more intuitive, thereby reducing the learning curve for operators. As a result, the market is trending towards more sophisticated, user-friendly, and interconnected devices, ultimately contributing to enhanced patient care and overall public health outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies
• Patent Analysis

Global Defibrillator Market Size by Type & CAGR (2025-2032)

• Market Overview
• Implantable cardioverter defibrillators
  • Transvenous implantable cardioverter defibrillators
  • Subcutaneous implantable cardioverter defibrillators
• External defibrillators
  • Manual & semi-automated external defibrillators
  • Fully automated external defibrillators
  • Wearable cardioverter defibrillators

Global Defibrillator Market Size by Patients type & CAGR (2025-2032)

• Market Overview
• Adult
• Pediatrics

Global Defibrillator Market Size by End Users & CAGR (2025-2032)

• Market Overview
• Hospitals, Clinics and Cardiac centres
• Pre-hospital care settings
• Public access markets
• Home care settings
• Alternate care facilities
• Other end users

Global Defibrillator Market Size & CAGR (2025-2032)

• North America (Type, Patients type, End Users)
  • US
  • Canada
• Europe (Type, Patients type, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Patients type, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Patients type, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Patients type, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZOLL Medical Corporation (Asahi Kasei) (USA/Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schiller AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Defibtech LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiac Science Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bexen Cardio (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Physio-Control Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CU Medical Systems Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metrax GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BPL Medical Technologies (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avive Solutions Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations